---
title: "Metamycoplasma gateae Osteomyelitis After Cat Bite: Case Report and Clinical Details"
id: "cdc-emerging-infectious-diseases-journal-3-osteomyelitis-caused-by-metamycoplasma-gateae-after-cat-bite-japan-2026"
canonical_url: "https://medichelpline.com/clinical-feed/cdc-emerging-infectious-diseases-journal-3-osteomyelitis-caused-by-metamycoplasma-gateae-after-cat-bite-japan-2026"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "CDC Emerging Infectious Diseases Journal"
source_url: "https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article"
published_at: "2026-11-05T05:00:00.000Z"
evidence_level: "Agency Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Metamycoplasma gateae Osteomyelitis After Cat Bite: Case Report and Clinical Details
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/cdc-emerging-infectious-diseases-journal-3-osteomyelitis-caused-by-metamycoplasma-gateae-after-cat-bite-japan-2026
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** CDC Emerging Infectious Diseases Journal
- **Source URL:** [Original Journal Publication](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article)
- **Published At:** 2026-11-05T05:00:00.000Z
- **Evidence Rating:** Agency Feed
## Executive GIST (TL;DR)
- A 39-year-old immunocompromised woman developed progressive right-hand infection after a cat bite sustained 42 days before hospital admission. - Initial diagnosis by a dermatologist was cellulitis; standard intravenous ceftriaxone followed by oral clindamycin did not resolve symptoms. - On admission she had fever, swelling, elevated leukocytes and C-reactive protein, hyperglycemia, and marked hypogammaglobulinemia documented by low IgG, IgA, and IgM levels. - Magnetic resonance imaging at admission demonstrated subcutaneous fluid collection and **osteomyelitis** of the third metacarpal bone; earlier MRI (31 days before admission) had shown no bone involvement. - Incision and drainage were performed; pus and tissue specimens were cultured under aerobic, anaerobic, and enrichment conditions, but routine cultures and blood cultures remained negative. - Empirical therapy began with piperacillin/tazobactam; therapy was switched to ampicillin/sulbactam on hospital day 5 and back to piperacillin/tazobactam on day 8 because of clinical worsening. - On day 11, 16S rRNA gene sequencing from tissue identified **Metamycoplasma gateae** (GenBank accession no. LC934417) with 99.86% sequence similarity to a reference strain; investigators deposited the sequence in GenBank. - Because swelling persisted, clinicians started **minocycline** (100 mg every 12 hours) on day 12; clinical improvement in erythema, swelling, and range of motion was observed by day 19, and the patient was discharged on day 29 with recommendation to continue oral minocycline for >4 weeks. - The report notes that no standardized human treatment exists for **M. gateae**; minocycline was chosen for bone penetration. - Investigators cautioned that prior antimicrobial exposure may reduce culture yield, whole-genome sequencing was not performed so misclassification cannot be excluded, and **M. gateae** infection should be considered in immunocompromised patients with cat-bite exposure and negative routine cultures.
## Clinical Analysis & Structured Key Points
[Skip directly to page options](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#share-nav) [Skip directly to A-Z link](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#az-large) ![](https://wwwnc.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/us_flag_small.png) An official website of the United States government Here's how you know ![](https://wwwnc.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/icon-dot-gov.svg) **Official websites use .gov** A .gov website belongs to an official government organization in the United States. ![](https://wwwnc.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/icon-https.svg) **Secure .gov websites use HTTPS** A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. [CDC Home](https://wwwnc.cdc.gov/) [ ![Centers for Disease Control and Prevention](https://wwwnc.cdc.gov/TemplatePackage/5.0/img/logo/cdc-logo-tag-right.svg) ](https://www.cdc.gov/) Emerging Infectious Diseases ![](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) [A-Z Index](https://www.cdc.gov/az/) × Submit [A-Z Index](https://www.cdc.gov/az/) × Submit [A-Z Index](https://www.cdc.gov/az/) Search Dropdown × Submit Emerging Infectious Diseases * [About the Journal](https://wwwnc.cdc.gov/eid/about) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **About the Journal** * [General Information](https://wwwnc.cdc.gov/eid/about/general) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **General Information** * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **About the Journal****General Information** * [Background and Goals](https://wwwnc.cdc.gov/eid/about/background) * [Editors](https://wwwnc.cdc.gov/eid/about/editors) * [Editorial Board](https://wwwnc.cdc.gov/eid/about/editorial-board) * [Staff](https://wwwnc.cdc.gov/eid/about/staff) * [ Home](https://wwwnc.cdc.gov/) * [Contact](https://wwwnc.cdc.gov/eid/contact) * [EID Journal Report 2025](https://wwwnc.cdc.gov/eid/pdfs/JournalReport_2025.pdf) * [ Home](https://wwwnc.cdc.gov/) * [Articles](https://wwwnc.cdc.gov/eid/) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **Articles** * [November 2026](https://wwwnc.cdc.gov/eid/current) * [Wastewater Surveillance](https://wwwnc.cdc.gov/eid/articles/issue/32/13/table-of-contents) * [Early Release](https://wwwnc.cdc.gov/eid/early-release) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **Early Release** * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **Articles****Early Release** * [Osteomyelitis Caused by Metamycoplasma gateae after Cat Bite, Japan, 2026](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **Osteomyelitis Caused by Metamycoplasma gateae after Cat Bite, Japan, 2026** * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **Early Release****Osteomyelitis Caused by Metamycoplasma gateae after Cat Bite, Japan, 2026** * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **Articles****Early Release****Osteomyelitis Caused by Metamycoplasma gateae after Cat Bite, Japan, 2026** * [Figure](https://wwwnc.cdc.gov/eid/article/32/12/26-0515-f1) * [Appendix](https://wwwnc.cdc.gov/eid/article/32/12/26-0515-app1.pdf) * [ Home](https://wwwnc.cdc.gov/) * [ Home](https://wwwnc.cdc.gov/) * [Past Issues](https://wwwnc.cdc.gov/eid/past-issues/volume-32) * [Medscape CME](https://wwwnc.cdc.gov/eid/articles/cme) * [ICEID](https://wwwnc.cdc.gov/eid/page/iceid) * [ Home](https://wwwnc.cdc.gov/) * [Search](https://wwwnc.cdc.gov/eid/Search) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **Search** * [Advanced Article Search](https://wwwnc.cdc.gov/eid/AdvancedSearch) * [Articles by Country Search](https://wwwnc.cdc.gov/eid/ArticleMap) * [Spotlight Topics](https://wwwnc.cdc.gov/eid/spotlight) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **Spotlight Topics** * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **Search****Spotlight Topics** * [Antimicrobial Resistance Spotlight](https://wwwnc.cdc.gov/eid/spotlight/antimicrobial-resistance) * [Coronavirus Spotlight](https://wwwnc.cdc.gov/eid/spotlight/coronavirus) * [Ebola Spotlight](https://wwwnc.cdc.gov/eid/spotlight/ebola) * [Etymologia](https://wwwnc.cdc.gov/eid/articles/etymologia) * [Foodborne Diseases and Outbreaks Spotlight](https://wwwnc.cdc.gov/eid/spotlight/foodborne-diseases) * [Fungal Diseases](https://wwwnc.cdc.gov/eid/spotlight/fungal) * [Hantavirus Spotlight](https://wwwnc.cdc.gov/eid/spotlight/hantavirus) * [HIV/AIDS Spotlight](https://wwwnc.cdc.gov/eid/spotlight/hiv) * [Influenza Spotlight](https://wwwnc.cdc.gov/eid/spotlight/influenza) * [Lyme Disease Spotlight](https://wwwnc.cdc.gov/eid/spotlight/lyme-disease) * [Malaria Spotlight](https://wwwnc.cdc.gov/eid/spotlight/malaria) * [MERS Spotlight](https://wwwnc.cdc.gov/eid/spotlight/mers) * [Mpox Spotlight](https://wwwnc.cdc.gov/eid/spotlight/mpox) * [Pneumonia Spotlight](https://wwwnc.cdc.gov/eid/spotlight/pneumonia) * [Rabies Spotlight](https://wwwnc.cdc.gov/eid/spotlight/rabies) * [Ticks Spotlight](https://wwwnc.cdc.gov/eid/spotlight/ticks) * [Tuberculosis/Mycobacteria](https://wwwnc.cdc.gov/eid/spotlight/tuberculosis) * [Zika Spotlight](https://wwwnc.cdc.gov/eid/spotlight/zika) * [ Home](https://wwwnc.cdc.gov/) * [Article Type Search](https://wwwnc.cdc.gov/eid/ArticleTypeSearch) * [EID on PubMed Central](https://www.ncbi.nlm.nih.gov/pmc/journals/782/) * [ Home](https://wwwnc.cdc.gov/) * [Subscribe](https://wwwnc.cdc.gov/eid/subscriptions) * [Author Resource Center](https://wwwnc.cdc.gov/eid/page/author-resource-center) * [Peer Reviewers](https://wwwnc.cdc.gov/eid/reviewers) * [Podcasts](https://wwwnc.cdc.gov/eid/podcasts) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) **Podcasts** * [Search](https://wwwnc.cdc.gov/eid/podcasts/search) * [ Home](https://wwwnc.cdc.gov/) * [Social Media](https://wwwnc.cdc.gov/eid/page/social-media) * [ Press & Media Information](https://wwwnc.cdc.gov/eid/press) * [ Home](https://wwwnc.cdc.gov/) 1. [EID Journal](https://wwwnc.cdc.gov/eid/) 2. [Volume 32](https://wwwnc.cdc.gov/eid/early-release) 3. [Early Release](https://wwwnc.cdc.gov/eid/early-release#issue-1348) 4. [Main Article](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) * [Facebook](https://www.facebook.com/sharer/sharer.php?u=%2Feid%2Farticle%2F32%2F12%2F26-0515_article "Share to Facebook") * [Twitter](http://twitter.com/share?url=%2Feid%2Farticle%2F32%2F12%2F26-0515_article&text= "Share to Twitter") * [LinkedIn](https://www.linkedin.com/shareArticle?url=%2Feid%2Farticle%2F32%2F12%2F26-0515_article&title= "Share to LinkedIn") * [Syndicate](https://tools.cdc.gov/medialibrary/index.aspx#/sharecontent//eid/article/32/12/26-0515_article "Embed this Page") [ Emerging Infectious Disease journal ISSN: 1080-6059 ](https://wwwnc.cdc.gov/eid/) _Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released._ #### Volume 32, Number 12—December 2026 ##### _Research Letter_ ### Osteomyelitis Caused by _Metamycoplasma gateae_ after Cat Bite, Japan, 2026 On This Page [Research Letter](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) * * * [Suggested Citation](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) Figures [Figure](https://wwwnc.cdc.gov/eid/article/32/12/26-0515-f1) Downloads [Appendix ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515-app1.pdf) * * * [RIS [TXT - 2 KB] ](https://wwwnc.cdc.gov/eid/article/32/12/26-0515.ris) Article Metrics [Metric Details](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article) Takehiro Hashimoto[![Comments to Author](https://wwwnc.cdc.gov/eid/content/images/icon/email.gif)](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#comment) , Miyuki Uehara, Yuta Shingai, Daisuke Tamura, Kazunori Kimitsuki, Hirotaka Shibata, and Kazufumi Hiramatsu Author affiliation: Oita University Hospital, Yufu, Japan (T. Hashimoto, K. Hiramatsu); Oita University Faculty of Medicine, Yufu (M. Uehara, Y. Shingai, D. Tamura, K. Kimitsuki, H. Shibata) [Suggested citation for this article](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#suggestedcitation) ### Abstract We report a case of osteomyelitis caused by _Metamycoplasma gateae_ after a cat bite in an immunocompromised patient in Japan. No standardized treatment has been established; however, the patient recovered after surgery and minocycline treatment. Clinicians should consider _M. gateae_ infection in immunocompromised patients with unidentified infections and cat-bite exposure. _Metamycoplasma gateae_ , a member of the family Mycoplasmataceae, was first isolated from cat saliva in 1967 ([_1_](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#r1 "1")) and reclassified from _Mycoplasma_ into the genus _Metamycoplasma_ in 2018 ([_2_](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#r2 "2")). Although _M. gateae_ is known to colonize cats and cause feline infections ([_3_](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#r3 "3")–[ _6_](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#r6 "6")), human infections have not been reported. We report a case of osteomyelitis caused by _M. gateae_ in an immunocompromised patient with cat-bite exposure. A 39-year-old woman was admitted to Oita University Hospital with fever and pain in her right hand, which her pet cat had bitten 42 days before admission. She had systemic lupus erythematosus treated with methylprednisolone (8 mg/d) and mycophenolate mofetil (2,000 mg/d) and type 1 diabetes mellitus managed with continuous subcutaneous insulin infusion. Swelling and pain in the right hand developed 32 days before admission and was diagnosed by a dermatologist at the hospital as cellulitis and treated with intravenous ceftriaxone, followed by oral clindamycin for 2 weeks. Magnetic resonance imaging, performed 31 days before hospital admission, had shown no osteomyelitis. The pain persisted despite treatment. Two days before admission, swelling spread to the wrist and fourth and fifth proximal interphalangeal joints, and fever (38.3°C) developed along with worsening pain. At admission, physical examination revealed swelling and tenderness of the right hand. Laboratory tests showed elevated leukocytes (9,660 cells/μL, reference range 3,300–8,600 cells/μL), C-reactive protein (15.3 mg/dL, reference range 0.0–0.14 mg/dL), and glycated hemoglobin (7.6%, reference range 4.9%–6.0%) and markedly decreased serum immunoglobulin levels (88 mg/dL IgG [reference range 861–1,747 mg/dL]; 13 mg/dL IgA [reference range 93–393 mg/dL]; and 2 mg/dL IgM [reference range 50–269 mg/dL]). Magnetic resonance imaging revealed subcutaneous fluid collection within the dorsum of the hand and osteomyelitis of the third metacarpal bone, leading to a diagnosis of cellulitis with osteomyelitis. We performed an incision with drainage and collected pus, tissue, and blood culture specimens. We cultured the pus and tissue specimens in aerobic, anaerobic, and enrichment media under standard conditions ([Appendix](https://wwwnc.cdc.gov/eid/article/32/12/26-0515-app1.pdf)). We initiated empirical antimicrobial drug therapy with piperacillin/tazobactam (4/0.5 g every 8 h). Pus and tissue cultures were negative; serologic testing for _Bartonella_ antibodies was negative. We changed the antimicrobial drug therapy to ampicillin/sulbactam (2/1 g every 6 h) on day 5. However, pain in the right hand worsened; we changed the treatment back to piperacillin/tazobactam only on day 8. Figure ![Patient’s right hand in case study of osteomyelitis caused by Metamycoplasma gateae after cat bite, Japan, 2026. A\) Erythema and swelling of the wrist, dorsum of the hand, and proximal interphalangeal joints of the fourth and fifth fingers on day 12 after hospital admission, immediately before initiation of minocycline therapy. B\) Reduced erythema and swelling on day 20, eight days after initiation of minocycline therapy.](https://wwwnc.cdc.gov/eid/images/26-0515-F1-tn.jpg) [Figure](https://wwwnc.cdc.gov/eid/article/32/12/26-0515-f1 "Figure"). Patient’s right hand in case study of osteomyelitis caused by _Metamycoplasma gateae_ after cat bite, Japan, 2026. A) Erythema and swelling of the wrist, dorsum of the hand, and... On day 11, 16S rRNA gene sequencing of DNA from a tissue specimen identified _M. gateae_ as the causative bacterium. The nucleotide sequence was deposited in GenBank (accession no. LC934417). The sequence showed 99.86% (1,450/1,452 nt) sequence similarity to a reference strain (GenBank accession no. CP143578.1) ([Appendix](https://wwwnc.cdc.gov/eid/article/32/12/26-0515-app1.pdf) Table). Because the swelling persisted on day 12 ([Figure](https://wwwnc.cdc.gov/eid/article/32/12/26-0515-f1), panel A), we switched treatment to minocycline (100 mg every 12 h). The swelling improved by day 19 ([Figure](https://wwwnc.cdc.gov/eid/article/32/12/26-0515-f1), panel B) along with gradual recovery of the range of motion. We discharged the patient on day 29 and advised her to continue oral minocycline for >4 weeks. _M. gateae_ can cause severe infections in feline hosts, including erosive polyarthritis, tenosynovitis, ulcerative keratitis, and lower respiratory tract infections, particularly in immunocompromised cats ([_3_](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#r3 "3")–[ _6_](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#r6 "6")). _M. gateae_ infections have not been reported in humans. Because of the high prevalence of _M. gateae_ in domestic cat populations, which is present in >80% of adult cats ([_7_](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#r7 "7")), cases of human infection might be unrecognized. No standardized antimicrobial drug treatment regimens have been established for _M. gateae_ infections in humans. We selected minocycline because of its high level of bone penetration. The patient’s immunocompromised state, caused by hypogammaglobulinemia, steroid therapy, and type 1 diabetes, might have contributed to infection susceptibility. Hypogammaglobulinemia is a known risk factor for _Mycoplasma_ infections ([_8_](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#r8 "8")). No pathogens were identified in tissue or blood cultures, and β-lactam/β-lactamase inhibitor therapy was ineffective. However, BLAST ( [External Link](https://blast.ncbi.nlm.nih.gov)) analysis of the 16S rRNA gene sequence obtained from a tissue sample revealed the highest sequence identity to _M. gateae_ (99.86% identity to GenBank accession nos. CP143578.1 and NR_029180.1). The next closest match was _Mycoplasma arginini_ (99.31% sequence identity), a common colonizer of feline respiratory tracts ([_8_](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#r8 "8")). The differences in sequence identities support the identification of the isolate as _M. gateae_. We did not perform whole-genome sequencing, and misclassification cannot be excluded. Clinicians should consider _M. gateae_ in immunocompromised patients with indolent infections after animal contact or bites. If _Mycoplasma_ infection is suspected, specimens should be cultured on specialized media under appropriate conditions ([_8_](https://wwwnc.cdc.gov/eid/article/32/12/26-0515_article#r8 "8")). Previous antimicrobial drug exposure might have reduced culture yield and masked other pathogens. Although incision and drainage might have contributed to recovery, we did not observe clinical improvement until minocycline was initiated, suggesting that targeted antimicrobial drug therapy played the primary role in clinical improvement. In conclusion, we report a case of _M. gateae_ –mediated osteomyelitis in an immunocompromised patient. Negative routine tissue and blood cultures, despite cat-bite exposure, together with a poor clinical response to β-lactam/β-lactamase inhibitor therapy prompted 16S rRNA gene sequencing, which identified _M. gateae_. _M. gateae_ infection should be considered in patients with cat-bite exposure when routine cultures are negative and β-lactam/β-lactamase inhibitor therapy is ineffective. Dr. Hashimoto is a medical doctor at the Infection Control Center, Oita University Hospital, Yufu, Japan. His research interests include microbiology and infectious diseases. [TopExternal Link](javascript:void\(0\)) ### Acknowledgment The patient consented to publication of her case details and photographs of her right hand. [Top](javascript:void\(0\)) ### References 1. Cole BC, Golightly L, Ward JR. Characterization of _Mycoplasma_ strains from cats. J Bacteriol. 1967;94:1451–8. [DOIExternal Link](https://doi.org/10.1128/jb.94.5.1451-1458.1967 "DOI")[PubMedExternal Link](https://pubmed.ncbi.nlm.nih.gov/4168314 "PubMed")[Google ScholarExternal Link](https://scholar.google.com/scholar_lookup?doi=10.1128%2fjb.94.5.1451-1458.1967&pmid=4168314 "Google Scholar") 2. Munson E, Lawhon SD, Burbick CR, Zapp A, Villaflor M, Thelen E. An update on novel taxa and revised taxonomic status of bacteria isolated from domestic animals described in 2018 to 2021. J Clin Microbiol. 2023;61:e0028122. [DOIExternal Link](https://doi.org/10.1128/jcm.00281-22 "DOI")[PubMedExternal Link](https://pubmed.ncbi.nlm.nih.gov/36533907 "PubMed")[Google ScholarExternal Link](https://scholar.google.com/scholar_lookup?doi=10.1128%2fjcm.00281-22&pmid=36533907 "Google Scholar") 3. Moise NS, Crissman JW, Fairbrother JF, Baldwin C. _Mycoplasma gateae_ arthritis and tenosynovitis in cats: case report and experimental reproduction of the disease. Am J Vet Res. 1983;44:16–21. [DOIExternal Link](https://doi.org/10.2460/ajvr.1983.44.01.16 "DOI")[PubMedExternal Link](https://pubmed.ncbi.nlm.nih.gov/6824220 "PubMed")[Google ScholarExternal Link](https://scholar.google.com/scholar_lookup?doi=10.2460%2fajvr.1983.44.01.16&pmid=6824220 "Google Scholar") 4. Zeugswetter F, Hittmair KM, de Arespacochaga AG, Shibly S, Spergser J. Erosive polyarthritis associated with _Mycoplasma gateae_ in a cat. J Feline Med Surg. 2007;9:226–31. [DOIExternal Link](https://doi.org/10.1016/j.jfms.2006.10.002 "DOI")[PubMedExternal Link](https://pubmed.ncbi.nlm.nih.gov/17175189 "PubMed")[Google ScholarExternal Link](https://scholar.google.com/scholar_lookup?doi=10.1016%2fj.jfms.2006.10.002&pmid=17175189 "Google Scholar") 5. Gray LD, Ketring KL, Tang YW. Clinical use of 16S rRNA gene sequencing to identify _Mycoplasma felis_ and _M. gateae_ associated with feline ulcerative keratitis. J Clin Microbiol. 2005;43:3431–4. [DOIExternal Link](https://doi.org/10.1128/JCM.43.7.3431-3434.2005 "DOI")[PubMedExternal Link](https://pubmed.ncbi.nlm.nih.gov/16000470 "PubMed")[Google ScholarExternal Link](https://scholar.google.com/scholar_lookup?doi=10.1128%2fJCM.43.7.3431-3434.2005&pmid=16000470 "Google Scholar") 6. Reed N, Simpson K, Ayling R, Nicholas R, Gunn-Moore D. _Mycoplasma_ species in cats with lower airway disease: improved detection and species identification using a polymerase chain reaction assay. J Feline Med Surg. 2012;14:833–40. [DOIExternal Link](https://doi.org/10.1177/1098612X12451796 "DOI")[PubMedExternal Link](https://pubmed.ncbi.nlm.nih.gov/22718951 "PubMed")[Google ScholarExternal Link](https://scholar.google.com/scholar_lookup?doi=10.1177%2f1098612X12451796&pmid=2271
## Related Clinical Research

- [Nuclear-transport–targeting peptides (SN50 family) as broad anti-inflammatory agents](https://medichelpline.com/clinical-feed/frontiers-in-immunology-17-targeting-the-nuclear-gateway-a-new-class-of-cell-penetrating-peptides-for.md)
- [SGLT2 Inhibitors and Rheumatoid Arthritis Risk in Type 2 Diabetes: Summary of Reported Emulated Ta](https://medichelpline.com/clinical-feed/frontiers-in-immunology-19-the-association-between-sglt2-inhibitors-and-rheumatoid-arthritis-risk-in-type.md)
- [High blood pressure in Ugandan children and adolescents with Type 1 diabetes: multicenter prevalen](https://medichelpline.com/clinical-feed/plos-one-11-high-blood-pressure-among-children-and-adolescents-with-type-1-diabetes.md)
- [Type 1 Diabetes Care: Hypoglycemia Burden and Beta-Cell Replacement Research](https://medichelpline.com/clinical-feed/endocrine-news-0-type-1-diabetes-setting-the-scene-and-the-evolution-of-type-1-diabetes-care.md)
- [MiniMed 780G Performance in Asian Adults With Type 1 Diabetes: 24-Week Exploratory Study](https://medichelpline.com/clinical-feed/pubmed-43056643.md) (DOI: 10.2196/94885)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.